• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Diabetic Retinopathy Drug Pipeline Capsule - 2012 Product Image

Global Diabetic Retinopathy Drug Pipeline Capsule - 2012

  • ID: 2011303
  • January 2012
  • Region: Global
  • 13 pages
  • Fore Pharma

Fore Pharma’s latest report ‘Global Diabetic Retinopathy Drug Pipeline Capsule – 2012’ is an outline of all the key research and development (R&D) activities of the global diabetic retinopathy drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery. The report is up-to-date with full coverage of the licensing activities and partnerships.

This report helps executives to keep a track of their competitors and understand their pipeline molecules. The information presented in this report can be used for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered / preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies READ MORE >

1. Diabetic Retinopathy: Disease Definition
2. Diabetic Retinopathy Drug Pipeline Overview
3. Diabetic Retinopathy Phase 3 Clinical Trial Drug Pipeline Insights
4. Diabetic Retinopathy Phase 2 Clinical Trial Drug Pipeline Insights
5. Diabetic Retinopathy Phase 1 Clinical Trial Drug Pipeline Insights
6. Diabetic Retinopathy Preclinical Research Drug Pipeline Insights
7. Diabetic Retinopathy Drug Discovery Pipeline Insights
8. Geographic Landscape of Diabetic Retinopathy R&D Activities
8.1 Diabetic Retinopathy R&D Activities in North America
8.2 Diabetic Retinopathy R&D Activities in Europe
9 Licensing Activities / Partnerships in the Global Diabetic Retinopathy Drug Market
10 Research Methodology
Table 1: Diabetic Retinopathy Drug Pipeline: Phase 3 Clinical Trial
Table 2: Diabetic Retinopathy Drug Pipeline: Phase 2 Clinical Trial
Table 3: Diabetic Retinopathy Drug Pipeline: Phase 1 Molecules
Table 4: Diabetic Retinopathy Drug Pipeline: Preclinical Research
Table 5: Diabetic Retinopathy R&D Activities by Geography
Table 6: Diabetic Retinopathy Drug Pipeline: North America
Table 7: Diabetic Retinopathy Drug Pipeline: Europe
Table 8: Diabetic Retinopathy Drug Pipeline: Licensing Activities
Figure 1 : Diabetic Retinopathy Drug Pipeline Molecules by Stages
Figure 2 : Diabetic Retinopathy R&D Activities by Geography

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos